Compare Centrus Energy Corp (LEU) vs New York Times Co (NYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs New York Times Co — how do they compare? Centrus Energy Corp trades at $142.44 (market cap $2.91B), while New York Times Co trades at $66.32 (market cap $10.74B). The key difference: New York Times Co is far larger — about 3.7× Centrus Energy Corp's market cap, and New York Times Co pays a 1.38% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 29 Days and New York Times Co for 81 Days on average.
| LEU | NYT | |
|---|---|---|
Market Cap | $2.91B | $10.74B |
Volume | 903,777 | 2,096,352 |
Sector | Energy | Media |
52-Week High | $436.00 | $85.86 |
52-Week Low | $138.18 | $54.66 |
Typical Hold Time | 29 Days | 81 Days |
Enterprise Value | $2.22B | $10.14B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $142.44, down 3.19% on the day, with a bearish technical outlook despite recent earnings beats. The stock shows elevated valuation metrics (P/E 75.18, P/S 6.68) while profitability metrics remain solid (net margin 10.23%, ROE 8.05%). Recent news highlights the company's strategic position as a key HALEU supplier amid growing nuclear energy demand, with multiple new supply contracts announced in September 2026.
LEU presents a high-risk, high-reward opportunity with analyst consensus price target of $218.10 (53% upside) but significant execution risks. The company's growth depends on successful expansion of domestic uranium enrichment capacity and capitalizing on nuclear energy tailwinds, though recent profit margin compression and negative operating cash flow projections for 2026 warrant caution.
The New York Times Company (NYT) trades at $66.60, up 2.62% today, reflecting strong momentum after three consecutive quarterly earnings beats. Revenue and net income have grown steadily from 2022 to 2025, with profit margins expanding to 12.17%. The stock shows a bullish technical signal overall, supported by positive cash flow trends and a declared quarterly dividend of $0.23 per share. However, a recent shareholder lawsuit alleging reporting bias introduces reputational risk.
Outlook remains positive given consistent earnings outperformance and a consensus price target of $84.00, implying significant upside. Key risks include the ongoing lawsuit, competitive pressures in digital media, and potential volatility from the AI copyright dispute with OpenAI. The company's solid fundamentals and analyst support suggest resilience, but investors should weigh legal and market challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →
